Skip to main content

and
  1. Article

    Research codes and contracts do not guarantee equitable research with Indigenous communities

    Research codes and contracts have been developed to protect Indigenous and marginalized peoples from exploitation and to promote inclusion, so that research will become more beneficial to them. We highlight th...

    Stasja Koot, Julie Grant, Moses //Khumûb, Kileni Fernando in Nature Ecology & Evolution (2023)

  2. Article

    Open Access

    CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension

    Patients with pulmonary arterial hypertension (PAH) carrying bone morphogenetic protein receptor type 2 (Bmpr2) mutations present earlier with severe hemodynamic compromise and have poorer survival outcomes than ...

    Jane Chanda Kabwe, Hirofumi Sawada, Yoshihide Mitani in Respiratory Research (2022)

  3. Article

    Open Access

    Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension

    Rats with chronic hypoxia-induced non-inflammatory pulmonary hypertension (PH) are resistant to ventilator-induced lung injury. We investigated the effect of high tidal volume ventilation in another model of P...

    Masako Kawai, Erquan Zhang, Jane Chanda Kabwe, Amphone Okada in BMC Pulmonary Medicine (2022)

  4. Article

    Open Access

    Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats

    Preventing pulmonary vascular remodeling is a key strategy for pulmonary hypertension (PH). Causes of PH include pulmonary vasoconstriction and inflammation. This study aimed to determine whether cilostazol (C...

    Toshikazu Ito, Erquan Zhang, Ayaka Omori, Jane Kabwe in BMC Pulmonary Medicine (2021)

  5. No Access

    Article

    Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats

    The purpose of the present study was to determine if sarpogrelate hydrochloride (SPG), a serotonin 5HT2A receptor antagonist, prevented the development of chronic hypoxia-induced pulmonary hypertension (PH) a...

    Erquan Zhang, Junko Maruyama, Ayumu Yokochi, Yoshihide Mitani in Journal of Anesthesia (2015)

  6. Article

    Open Access

    Thrombomodulin protects against lung damage created by high level of oxygen with large tidal volume mechanical ventilation in rats

    Ventilator-induced lung injury (VILI) is associated with inflammatory responses in the lung. Thrombomodulin (TM), a component of the coagulation system, has anticoagulant and anti-inflammatory effects. We hypo...

    Yoshiaki Iwashita, Erquan Zhang, Junko Maruyama, Ayumu Yokochi in Journal of Intensive Care (2014)

  7. No Access

    Article

    Effect of thrombomodulin on the development of monocrotaline-induced pulmonary hypertension

    The purpose of the present study was to investigate whether thrombomodulin (TM) prevents the development of pulmonary hypertension (PH) in monocrotaline (MCT)-injected rats.

    Yasuharu Yamada, Junko Maruyama, Erquan Zhang, Amphone Okada in Journal of Anesthesia (2014)

  8. No Access

    Article

    Skin ulcer is a predictive and prognostic factor of acute or subacute interstitial lung disease in dermatomyositis

    The aim of this study was to determine whether skin ulcer can be used as a predictive and prognostic factor of acute/subacute interstitial lung disease (ILD) in Japanese patients with dermatomyositis (DM). We ...

    Kazuyoshi Ishigaki, Junko Maruyama, Noboru Hagino in Rheumatology International (2013)

  9. No Access

    Article

    Colforsin-induced vasodilation in chronic hypoxic pulmonary hypertension in rats

    Colforsin, a water-soluble forskolin derivative, directly activates adenylate cyclase and thereby increases the 3′,5′-cyclic adenosine monophosphate (cAMP) level in vascular smooth muscle cells. In this study,...

    Ayumu Yokochi, Hiroo Itoh, Junko Maruyama, Erquan Zhang in Journal of Anesthesia (2010)

  10. No Access

    Article

    A Novel Inhibitor of Inducible Nitric Oxide Synthase, ONO-1714, Does Not Ameliorate Hypoxia-induced Pulmonary Hypertension in Rats

    A recent study showed that long-term administration of the inducible nitric oxide synthase (iNOS) inhibitor L-NIL reduced the development of pulmonary hypertension. The purpose of the present study was to iden...

    Bao Hua Jiang, Junko Maruyama, Ayumu Yokochi, Yoshihide Mitani, Kazuo Maruyama in Lung (2007)

  11. Article

    Effect of nicardipine on pulmonary hypertension after repair of congenital heart defects in early postoperative period

    We examined the effect of nicardipine and hyperventilatin on pulmonary arterial pressure (PAP) in four patients with pulmonary hypertension in congenital heart defect especially in the early postoperative peri...

    Kazuo Maruyama, Junko Maruyama, Hirofumi Utsunomiya in Journal of Anesthesia (1993)

  12. Article

    Whole body oxygen consumption after hypothermic cardiopulmonary bypass

    Whole body oxygen consumption and the substrate for energy production during the post-bypass period have not been clarified. We hypothesized that the substrate composition for energy production during post-byp...

    Kazuo Maruyama, Hiroshi Hashimoto, Kazutoshi Nakamura in Journal of Anesthesia (1993)